Universidade Federal de Uberlândia - UFU, School of Dentistry, Department of Periodontology, Pará, Av., 1760-1844 - Umuarama, Uberlândia, MG, 38405-320, Brazil.
Oral Maxillofac Surg. 2024 Jun;28(2):919-924. doi: 10.1007/s10006-024-01223-4. Epub 2024 Feb 15.
The aim of this study was to compare the analgesic efficacy of 4% articaine associated with epinephrine (1:100,000), and 2% lidocaine associated with epinephrine (1:100,000) in third molar extraction surgery.
Sixty patients who underwent surgeries to extract upper and lower third molars were included in this split-mouth, double-blind, randomized, controlled trial. The groups in this study were divided according to the anesthetic solution used to provide local anesthesia during extraction of upper and lower third molars: (1) 4% articaine associated with epinephrine (1:100,000); (2) 2% lidocaine associated with epinephrine (1:100,000). The time to the beginning and end of the sensation of analgesia, pain sensation according to the VAS scale, and number of anesthetic tubes necessary for supplementation were analyzed.
It was found that the onset time for analgesia was shorter on the side anesthetized with articaine compared to the side anesthetized with lidocaine (122.1 ± 52.90 s vs. 144.5 ± 68.85 s) (p < 0.05). In addition, the number of tubes used for anesthetic supplementation was also reduced on the articaine side compared to the lidocaine side (0.26 ± 0.48 vs. 0.50 ± 0.75) (p < 0.05). There were no differences between the anesthetic solutions in the other evaluated parameters.
It can be concluded that the use of 4% articaine associated with epinephrine (1:100,000) reduced the time of onset of analgesia and the necessity for anesthetic supplementation in third molar extraction surgeries compared to the use of 2% lidocaine associated with epinephrine (1:100,000).
本研究旨在比较 4%阿替卡因联合肾上腺素(1:100000)与 2%利多卡因联合肾上腺素(1:100000)在第三磨牙拔除术中的镇痛效果。
本研究采用随机、双盲、对照的分组方法,将 60 例需行上下颌第三磨牙拔除术的患者分为两组,根据局麻药物的不同分为 4%阿替卡因联合肾上腺素(1:100000)组(A 组)和 2%利多卡因联合肾上腺素(1:100000)组(B 组)。记录两组患者感觉镇痛起效时间、疼痛视觉模拟评分(VAS)、追加麻醉药管数。
A 组患者的镇痛起效时间短于 B 组(122.1±52.90 s 比 144.5±68.85 s)(p<0.05)。A 组患者追加麻醉药管数少于 B 组(0.26±0.48 比 0.50±0.75)(p<0.05)。两组患者在其他评估参数上无差异。
与使用 2%利多卡因联合肾上腺素(1:100000)相比,4%阿替卡因联合肾上腺素(1:100000)在第三磨牙拔除术中可缩短镇痛起效时间,减少追加麻醉药管数。